NM_173551.5:c.1854C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP6_Very_StrongBP7BS1BS2
The NM_173551.5(ANKS6):c.1854C>T(p.Leu618Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00085 in 1,592,362 control chromosomes in the GnomAD database, including 17 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0047 ( 11 hom., cov: 33)
Exomes 𝑓: 0.00044 ( 6 hom. )
Consequence
ANKS6
NM_173551.5 synonymous
NM_173551.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.929
Publications
0 publications found
Genes affected
ANKS6 (HGNC:26724): (ankyrin repeat and sterile alpha motif domain containing 6) This gene encodes a protein containing multiple ankyrin repeats and a SAM domain. It is thought that this protein may localize to the proximal region of the primary cilium, and may play a role in renal and cardiovascular development. Mutations in this gene have been shown to cause a form of nephronophthisis (NPHP16), a chronic tubulo-interstitial nephritis. [provided by RefSeq, Jul 2015]
ANKS6 Gene-Disease associations (from GenCC):
- nephronophthisis 16Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- nephronophthisis 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nephronophthisis 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP6
Variant 9-98771014-G-A is Benign according to our data. Variant chr9-98771014-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262846.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.929 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00473 (721/152338) while in subpopulation AFR AF = 0.0168 (700/41594). AF 95% confidence interval is 0.0158. There are 11 homozygotes in GnomAd4. There are 364 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ANKS6 | ENST00000353234.5 | c.1854C>T | p.Leu618Leu | synonymous_variant | Exon 10 of 15 | 1 | NM_173551.5 | ENSP00000297837.6 | ||
| ANKS6 | ENST00000375019.6 | c.951C>T | p.Leu317Leu | synonymous_variant | Exon 9 of 15 | 5 | ENSP00000364159.2 | |||
| ANKS6 | ENST00000444472.5 | c.258C>T | p.Leu86Leu | synonymous_variant | Exon 3 of 9 | 2 | ENSP00000398648.1 | |||
| ANKS6 | ENST00000634393.1 | n.954C>T | non_coding_transcript_exon_variant | Exon 8 of 15 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00475 AC: 723AN: 152220Hom.: 11 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
723
AN:
152220
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00109 AC: 252AN: 232238 AF XY: 0.000769 show subpopulations
GnomAD2 exomes
AF:
AC:
252
AN:
232238
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000439 AC: 632AN: 1440024Hom.: 6 Cov.: 33 AF XY: 0.000353 AC XY: 253AN XY: 715856 show subpopulations
GnomAD4 exome
AF:
AC:
632
AN:
1440024
Hom.:
Cov.:
33
AF XY:
AC XY:
253
AN XY:
715856
show subpopulations
African (AFR)
AF:
AC:
550
AN:
32578
American (AMR)
AF:
AC:
27
AN:
41510
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25660
East Asian (EAS)
AF:
AC:
0
AN:
38022
South Asian (SAS)
AF:
AC:
2
AN:
82458
European-Finnish (FIN)
AF:
AC:
0
AN:
53160
Middle Eastern (MID)
AF:
AC:
4
AN:
5684
European-Non Finnish (NFE)
AF:
AC:
6
AN:
1101458
Other (OTH)
AF:
AC:
43
AN:
59494
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
30
61
91
122
152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00473 AC: 721AN: 152338Hom.: 11 Cov.: 33 AF XY: 0.00489 AC XY: 364AN XY: 74482 show subpopulations
GnomAD4 genome
AF:
AC:
721
AN:
152338
Hom.:
Cov.:
33
AF XY:
AC XY:
364
AN XY:
74482
show subpopulations
African (AFR)
AF:
AC:
700
AN:
41594
American (AMR)
AF:
AC:
11
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5170
South Asian (SAS)
AF:
AC:
0
AN:
4810
European-Finnish (FIN)
AF:
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3
AN:
68034
Other (OTH)
AF:
AC:
7
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
34
68
101
135
169
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Nephronophthisis 16 Benign:2
Dec 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Aug 04, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.